Spotlight on Poster Presenter: Dr. Sanya Arora at the 12th International Cancer, Oncology and Therapy Conference and Exhibition
Spotlight on Poster Presenter: Dr. Sanya Arora at the 12th International Cancer, Oncology and Therapy Conference and Exhibition
Dr. Sanya Arora: Advancing Translational Oncology Through Service Innovation and Clinical Excellence
The field of thoracic oncology continues to evolve rapidly, driven by breakthroughs in targeted therapies and immuno-oncology. Among the emerging voices contributing to this transformation is Dr. Sanya Arora, an Oncology Fellow at The London Clinic, whose work bridges the critical gap between clinical research and real-world healthcare delivery.
At the 12th International Cancer, Oncology and Therapy Conference and Exhibition, on April 09–10, 2026.Dr. Arora will present her poster titled “Structured Integration of Tarlatamab in Routine Thoracic Oncology: A Risk-Stratified Monitoring Pathway with Demonstrable Service Optimisation.” Her work reflects a forward-thinking approach to integrating novel therapeutics into routine clinical practice while maintaining efficiency, safety, and scalability.
Important Links:
Registration: https://cancer.utilitarianconferences.com/registration
Submit Abstract: https://cancer.utilitarianconferences.com/submit-abstract
Virtual Registration: https://cancer.utilitarianconferences.com/virtual-registration
Speaker Profile: https://cancer.utilitarianconferences.com/speaker/sanya-arora
Professional Background and Academic Expertise
Dr. Arora combines hands-on clinical oncology practice with strong academic training, including a Master’s degree in International Health Policy. This dual expertise enables her to approach oncology not only from a patient-care perspective but also through the lens of healthcare systems, policy, and service delivery.
Her research interests include:
Implementation science in oncology
Healthcare service innovation
Optimisation of novel cancer therapies in routine practice
Translational pathways from clinical trials to real-world care
This multidisciplinary focus positions her work at the intersection of clinical excellence and system-level impact.
Poster Focus: Structured Integration of Tarlatamab
Tarlatamab represents a promising advancement in thoracic oncology, particularly in the management of complex malignancies. However, the introduction of such therapies into routine care often presents logistical and clinical challenges.
Dr. Arora’s research proposes a risk-stratified monitoring pathway designed to:
Ensure patient safety through tailored monitoring strategies
Optimise resource allocation within oncology services
Facilitate seamless integration of novel therapies into standard workflows
Improve overall service efficiency without compromising clinical outcomes
Her model emphasizes structured implementation, ensuring that innovations in cancer treatment are not confined to clinical trials but are effectively translated into everyday clinical settings.
Contribution to Oncology Practice
This work highlights a critical shift in modern oncology—moving beyond drug development to focus on how therapies are implemented at scale. By developing practical frameworks for integrating treatments like Tarlatamab, Dr. Arora contributes to:
Enhanced patient access to advanced therapies
Improved healthcare system efficiency
Standardised care pathways across institutions
Evidence-based service redesign
Her approach underscores the importance of aligning innovation with operational feasibility in healthcare systems worldwide.
About the Conference
The 12th International Cancer, Oncology and Therapy Conference and Exhibition is a global platform that brings together leading oncologists, researchers, clinicians, and healthcare professionals to exchange knowledge and present cutting-edge research in cancer science and treatment.
Key Benefits of the Conference
Global Networking: Connect with international experts, clinicians, and researchers
Knowledge Exchange: Gain insights into the latest advancements in oncology and therapeutics
Research Presentation: Showcase innovative work through oral and poster presentations
Professional Development: Enhance clinical and academic expertise through expert-led sessions
Collaborative Opportunities: Foster interdisciplinary partnerships and research collaborations
Access to Innovations: Learn about emerging technologies, drugs, and treatment protocols
.png)
Comments
Post a Comment